Two Blokes

FDA staff raises eye damage concerns for GSK's blood cancer drug

  • click to rate
    Posted by Two Blokes Jul 15 - Filed in Stock - 1 view
    The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in patients.